SK Biopharm expands Latin America push with Brazil launch

SK Biopharmaceuticals said Wednesday it is accelerating its expansion into Latin America by launching its epilepsy treatment Cenobamate in Brazil, as the firm's CEO joined South Korean President Lee Jae Myung's economic delegation for the first time.

The only representative from Korea's pharmaceutical and biotechnology industry to participate in the presidential economic delegation to Brazil, SK Biopharmaceuticals signed a memorandum of understanding with Eurofarma, a local pharmaceutical powerh ...